Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Elicio Therapeutics: Fourth Quarter Financial Overview

Elicio Therapeutics: Fourth Quarter Financial Overview

101 finance101 finance2026/03/12 22:15
By:101 finance

Elicio Therapeutics Reports Fourth Quarter Financial Results

Elicio Therapeutics, Inc., headquartered in Boston, announced on Thursday that it recorded a net loss of $7.7 million for the fourth quarter.

The company’s quarterly loss equated to 49 cents per share.

Over the entire fiscal year, Elicio Therapeutics reported a total loss of $39.6 million, translating to $2.58 per share.


0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!